ClinicalTrials.Veeva

Menu

The Effectiveness of Augmented Reality to Enhance CPAP Therapy in OSA Patients (CPAP OSA)

N

National Cheng-Kung University

Status

Not yet enrolling

Conditions

Physical Symptoms
Quality of Life
Aherence
Mental Health

Treatments

Behavioral: With AR guided CPAP therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06520592
112-2628-B-110 -006 -MY3 (Other Grant/Funding Number)
A-ER-111-531

Details and patient eligibility

About

The goal of this clinical trial is to exam if artificial reality works to improve continuous positive airway pressure (CPAP) adherence in obstructive sleep apnea (OSA) patients. It will also learn about the feasibility of AR guided CPAP therapy. The main questions it aims to answer are:

Does AR guided CPAP therapy increase the adherence of CPAP therapy among OSA patients? What barriers do participants have when using AR guided CPAP therapy? Researchers will compare AR guided CPAP therapy to a control (standard of care) to see if AR guided CPAP therapy works to enhance the adherence of CPAP therapy.

Participants will:

  1. Take AR guided CPAP therapy or standard of care every day for 6 months
  2. Visit the clinic on baseline (t0), receiving CPAP therapy at the 1st month (t1), for checkups and tests, receiving CPAP therapy at the 3rd month (t2), receiving CPAP therapy at the 6th month (t3).
  3. Response their symptoms on each following time.

Full description

Participants will randomly assign to two group, for experimental group will be received AR guided CPAP therapy. In the control group will be received standard of care.

Enrollment

60 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (1) Diagnosed with moderate to severe obstructive sleep apnea (AHI≥15) through polysomnography (PSG).
  • (2) Age is equal to or greater than 20 years old or equal.

Exclusion criteria

  • (1) individuals who have previously used positive pressure ventilators for treatment,
  • (2) those diagnosed with central sleep apnea,
  • (3) those with uncontrolled acute mental illness,
  • (4) terminally ill patients.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

With AR guided CPAP therapy
Experimental group
Description:
OSA patientns were assigned to experimental group, they will be received AR guided CPAP therapy
Treatment:
Behavioral: With AR guided CPAP therapy
Standard of care
No Intervention group
Description:
OSA patientns were assigned to stand of care group, they will be not received AR guided CPAP therapy

Trial contacts and locations

1

Loading...

Central trial contact

Yen Chin Chen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems